In this article, I will be looking again at Chemours Company (NYSE: CC ). I've been making a bit of a tradition out of reporting on this company before the quarterly reports - so the same thing is what I'm doing here beforeAnalyst’s Disclosure:I/we have a beneficial long position in the shares of CC, EVKIY either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have ...